News | December 08, 2008

Slower Heart Rate May Translate into Longer Life

December 9, 2008 - Slowing heart rate with exercise and stress reduction may help extend life, reports the December 2008 issue of the Harvard Heart Letter.

Sixty years ago, researchers showed that men with fast resting heart rates were more likely to develop high blood pressure than those with slower rates. Since then, a high resting heart rate has been linked to atherosclerosis, sudden death, and an increased risk of dying from cardiovascular disease. The article states each pulse of blood puts a mild stress on artery walls. More beats per minute means more stress. A faster heartbeat also gives the coronary arteries less time to fill with blood. This can lead to an imbalance between heart cells’ demand for oxygen and the heart’s ability to provide it.

Resting heart rate seems to be a common denominator for various types of heart disease. A tantalizing possibility is that lowering your heart rate could help protect you from heart disease and may even let your heart beat for longer.

The Harvard Heart Letter notes that if a resting heart rate is high, patients can do something about it by exercising more and reducing stress. Exercising every day gradually slows the resting rate. The relaxation response, meditation, and other stress-busting techniques also lower heart rate over time.

For more information: www.health.harvard.edu/heart


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now